Cowen Prime Advisors’s UpHealth, Inc. UPH Stock Holding History

Cowen Prime Advisors’s Portfolio UPH Stock Details UPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29.3K	Hold	15,584	–	–	0.01%	151
2023 Q1	$27K	Hold	15,584	–	–	0.01%	154
2022 Q4	$25K	Buy	+15,584	New	+$60.7K	0.01%	151

Other funds holding UPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

KACA

Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

MAMNY

Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

Cowen Prime Advisors's UPH Position: Q2 2023 in Review

Cowen Prime Advisors held its UpHealth, Inc. (UPH) position steady in Q2 2023 at 15,584 shares worth $29.3K. The position accounts for 0.01% of the portfolio, ranked #151.

Cowen Prime Advisors first reported a position in UPH in Q4 2022 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold UPH as of Q2 2023.

Cowen Prime Advisors held 15,584 shares of UpHealth, Inc. worth $29.3K as of Q2 2023.
Cowen Prime Advisors left its UpHealth, Inc. share count unchanged in Q2 2023.
UpHealth, Inc. made up 0.01% of Cowen Prime Advisors's portfolio in Q2 2023, its #151 holding.
Cowen Prime Advisors first reported a position in UpHealth, Inc. in Q4 2022 and has held it in 3 quarters since.
32 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.